Cleary Gottlieb represented Viking Global Investors in the transaction.Viking Global Investors announced a PIPE investment in Inhibrx, Inc., a clinical-stage biopharmaceutical company dedicated to the development…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
